英文名称 |
中文名称 |
CAS |
(E/Z)-Doxepin Glucuronide
|
DOXEPIN GLUCURONIDE (MIXTURE OF Z AND E ISOMERS) |
788790-52-3 |
N-Desmethyl Doxepin HCl
|
N-去甲盐酸多塞平 |
2887-91-4 |
(Z)-Doxepin HCl
|
多塞平EP杂质D |
25127-31-5 |
1’-epi-Entecavir
|
|
|
Febuxostat Impurity 5
|
2-(3-氰基-4-羟基苯基)-4-甲基-1,3-噻唑-5-羧酸乙酯 |
161798-02-3 |
Trelagliptin Impurity 10
|
曲格列汀杂质10 |
|
Febuxostat Impurity 11
|
4-硝基邻苯二甲腈 |
31643-49-9 |
Febuxostat Impurity 16
|
Febuxostat Impurity 16 |
2473435-22-0 |
Vortioxetine Sulfoxide
|
|
|
Ibrutinib Impurity 4
|
伊布替尼杂质4 |
1807619-68-6 |
Vortioxetine Impurity 24
|
沃替西汀杂质24 |
|
Enzalutamide Impurity C
|
2-氟-4-溴苯甲酸甲酯 |
179232-29-2 |
Ibrutinib Impurity 8
|
伊布替尼中间体N-2 |
330786-24-8 |
Ibrutinib Impurity 3
|
Ibrutinib Impurity 3 |
1226872-27-0 |
Febuxostat Impurity (2,2'-(4-isobutoxy-1,3-phenylene)bis(4-methylthiazole-5-carboxylic acid))
|
非布索坦杂质9 |
1330632-48-8 |
Enzalutamide Impurity 2
|
4-异硫代氰酰基-2-(三氟甲基)苯甲腈 |
143782-23-4 |
Febuxostat Impurity 18
|
|
|
Febuxostat Impurity 19
|
非布索坦中间体杂质 |
118485-48-6 |
Febuxostat Impurity 3
|
非布索坦中间体 |
160844-75-7 |
Afatinib Impurity 2
|
阿法替尼杂质46 |
1449430-45-8 |
Trelagliptin Impurity 13
|
曲格列汀杂质 9 |
|
Trelagliptin Impurity 7
|
曲格列汀杂质7 |
|
Trelagliptin Impurity 9
|
曲格列汀杂质 8 |
|
Trelagliptin Impurity 16
|
曲格列汀杂质16 |
|
Febuxostat Impurity 7
|
非布司他杂质7 |
1350352-70-3 |
Febuxostat Impurity (4-Isobutoxy benzene-1,3-bis(carbothio amide))
|
非布索坦杂质O |
1330632-46-6 |
Febuxostat Impurity 2
|
2-(3-醛基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸乙酯 |
161798-03-4 |
4-Hydroxy Propranolol Sulfate Potassium Salt
|
4-Hydroxy Propranolol Sulfate Potassium Salt |
1261395-42-9 |
Trelagliptin Impurity 6
|
曲格列汀杂质6 |
|
Febuxostat Impurity (2-(3-carboxy-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid)
|
非布索坦杂质B |
1239233-87-4 |
Trelagliptin Impurity 15
|
曲格列汀杂质15 |
|
2-Hydroxy Propranolol HCl
|
2-羟基普萘洛尔盐酸盐 |
76275-62-2 |
Trelagliptin Impurity 4
|
曲格列汀杂质4 |
|
Febuxostat Impurity 9
|
非布索坦杂质T |
407582-48-3 |
(S)-Ibrutinib
|
(S)-依鲁替尼 |
936563-97-2 |
Febuxostat Impurity 15
|
|
|
Febuxostat Impurity 12
|
Febuxostat Impurity 12 |
|
4-Bromo-2-fluorobenzoic acid
|
4-溴-2-氟苯甲酸 |
112704-79-7 |
Febuxostat Impurity 1
|
2-(3-醛基-4-羟基苯基)-4-甲基噻唑-5-羧酸乙酯 |
161798-01-2 |
Febuxostat Impurity 10
|
Febuxostat Impurity 10 |
|
Febuxostat Impurity 14
|
非布索坦杂质14 |
1335202-60-2 |
Febuxostat Impurity 17
|
2-(3-氨甲酰基-4-羟基)苯基-4-甲基噻唑-5-甲酸乙酯 |
|
Vortioxetine Impurity 9 HCl
|
沃替西汀杂质9 |
|
Trelagliptin Impurity 5
|
曲格列汀杂质 |
77532-85-5 |
Trelagliptin Impurity 11
|
曲格列汀杂质11 |
|
5-Hydroxy Propranolol Glucuronide (Mixture of Diastereomers)
|
5-羟基普萘洛尔葡糖醛酸(非对映异构体混合物) |
127182-49-4 |
Trelagliptin Impurity 14
|
1-甲基巴比妥酸 |
2565-47-1 |
Febuxostat Impurity (Dimethyl 2,2'-(4-isobutoxy-1,3-phenylene)bis(4-methylthiazole-5-carboxylate))
|
非布司他杂质C |
1330632-47-7 |
Trelagliptin Impurity 12
|
曲格列汀杂质12 |
|
Trelagliptin Impurity 3
|
曲格列汀杂质 3 |
|
Febuxostat Impurity 6
|
非布司他杂质6 |
1271738-74-9 |
Febuxostat Impurity 8
|
Febuxostat Impurity 8 |
144060-62-8 |
Afatinib Impurity 5
|
N-(3-氯-4-氟苯基)-7-甲氧基-6-硝基喹唑啉-4-胺 |
179552-74-0 |
Afatinib Impurity A
|
4-【(3-氯-4-氟苯基)氨基】-6-硝基-7-【(R)-四氢呋喃-4-基氧基】-喹唑啉 |
402855-07-6 |
Trelagliptin Impurity 2
|
曲格列汀杂质2 |
|
Trelagliptin Impurity 8
|
曲格列汀杂质 1 |
|
Ibrutinib Impurity 5
|
伊布替尼杂质5 |
|
Vortioxetine Impurity 8
|
沃替西汀杂质8 |
|
Ibrutinib Impurity 6
|
伊布替尼杂质6 |
1917333-91-5 |
Ibrutinib Impurity 2
|
依鲁替尼杂质2 |
|
Febuxostat Impurity 13
|
Febuxostat Impurity 13 |
|
Posaconazole Impurity 34 Oxalate
|
|
|
Posaconazole Impurity 25 Oxalate
|
|
|
rac-Posaconazole Diastereoisomer Related Compound 3
|
RAC-泊沙康唑非对映异构体相关化合物3 |
|
Posaconazole Diastereoisomer Related Compound 8
|
(5R-CIS)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯 |
149809-43-8 |
Posaconazole Impurity 32 Oxalate
|
|
|
Posaconazole Impurity 23 Dihydrochloride
|
|
|
Posaconazole Impurity 35 Oxalate
|
|
|
N-Hydroxylated Vortioxetine Glucuronide
|
N-羟基化沃替西汀葡糖醛酸 |
|
Vortioxetine Impurity 13
|
1-(2-溴苯基)哌嗪 |
1011-13-8 |
Vortioxetine Impurity 18
|
DISULFIDE, BIS(2,4-DIMETHYLPHENYL) |
13616-83-6 |
Vortioxetine Impurity 16
|
2,4-DIMETHYL-1-(PHENYLTHIO)- BENZENE |
16704-47-5 |
Vortioxetine Impurity 10 HCl
|
沃替西汀杂质10 |
|
Vortioxetine Impurity 17
|
Vortioxetine Impurity 17 |
2368241-98-7 |
Vortioxetine Impurity 5
|
沃替西汀杂质5 |
|
Vortioxetine Impurity 26
|
沃替西汀杂质26 |
|
Vortioxetine Impurity 11
|
沃替西汀杂质11 |
|
Vortioxetine Impurity 21
|
沃替西汀杂质21 |
|
Vortioxetine Impurity 15
|
Vortioxetine Impurity 15 |
2099147-02-9 |
Vortioxetine Impurity 7
|
沃替西汀杂质7 |
|
Vortioxetine Impurity 12
|
沃替西汀杂质12 |
|
Vortioxetine Impurity 25
|
|
|
Vortioxetine Impurity 22
|
沃替西汀杂质22 |
|
Doxepin related compound C
|
多塞平杂质C |
4504-96-5 |
Propranolol N-Formyl Impurity
|
|
77252-67-0 |
Capecitabine Impurity 3 (Defluoro Capecitabine)
|
Capecitabine Impurity 3
(Defluoro Capecitabine) |
216450-02-1 |
(E)-Doxepin HCl
|
(E)-Doxepin hydrochloride |
4698-39-9 |
Doxepin EP Impurity B
|
11-[3-(二甲胺基)丙基]-6,11-二氢二BENZ[B,E]氧杂环庚烷-11-醇 |
4504-88-5 |
Nifuratel Impurity B
|
硝呋太尔杂质B |
736-53-8 |
Doxepin related compound A
|
6,11-二氢二苯并[b,e]氧杂卓-11-酮 |
4504-87-4 |
Doxepin
|
多虑平 |
1668-19-5 |
rac Propranolol β-D-Glucuronide Sodium Salt
|
|
|
5-Hydroxy Propranolol HCl
|
5-羟基普萘洛尔盐酸盐 |
62117-35-5 |
7-Hydroxy Propranolol Glucuronide (Mixture of Diastereomers)
|
(+/-)-7-羟基普萘洛尔葡糖苷酸 |
1418018-59-3 |
7-Hydroxy Propranolol HCl
|
7-羟基普萘洛尔盐酸盐 |
76275-67-7 |
Propranolol N-Acetyl Impurity
|
N-[2-羟基-3-(1-萘氧基)丙基】-N-(1-甲基乙基)甲酰胺 |
2007-11-6 |
Propranolol Impurity B
|
普萘洛尔杂质B |
83314-78-7 |
Propranolol Impurity A, diol derivative
|
3-(萘酚基)-1,2-二羟基丙烷 |
36112-95-5 |
rac-4-Hydroxy Propranolol HCl
|
4-羟基普萘洛尔盐酸盐 |
14133-90-5 |
Propranolol impurity C, bis-ether derivative
|
1,3-二(萘-1-基氧基)丙-2-醇 |
17216-10-3 |